In the first publicly available test results for Russia's already widely distributed vaccine, Sputnik V, it was shown to be 91.6 per cent effective against the coronavirus in Phase 3 trials, according to peer-reviewed results published in the 'Lancet', a British medical journal. The findings make Sputnik only the third vaccine to have an efficacy of over 90 per cent after a vaccine from US pharmaceutical giant Pfizer, produced with German biotech firm BioNTech, and one from US biotech firm Moderna. Almost 20,000 participants took part in the trial, with roughly three-quarters receiving the vaccine, while the remainder received a placebo. It marks the first large-scale, peer-reviewed results
Hence then, the article about covid 19 russian vaccine over 91 effective against coronavirus was published today ( ) and is available onGulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( COVID-19: Russian vaccine over 91% effective against coronavirus )